Sørensen, M.S.; Colding-Rasmussen, T.; Horstmann, P.F.; Hindsø, K.; Dehlendorff, C.; Johansen, J.S.; Petersen, M.M.
Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities. Cancers 2021, 13, 2833.
https://doi.org/10.3390/cancers13112833
AMA Style
Sørensen MS, Colding-Rasmussen T, Horstmann PF, Hindsø K, Dehlendorff C, Johansen JS, Petersen MM.
Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities. Cancers. 2021; 13(11):2833.
https://doi.org/10.3390/cancers13112833
Chicago/Turabian Style
Sørensen, Michala Skovlund, Thomas Colding-Rasmussen, Peter Frederik Horstmann, Klaus Hindsø, Christian Dehlendorff, Julia Sidenius Johansen, and Michael Mørk Petersen.
2021. "Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities" Cancers 13, no. 11: 2833.
https://doi.org/10.3390/cancers13112833
APA Style
Sørensen, M. S., Colding-Rasmussen, T., Horstmann, P. F., Hindsø, K., Dehlendorff, C., Johansen, J. S., & Petersen, M. M.
(2021). Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities. Cancers, 13(11), 2833.
https://doi.org/10.3390/cancers13112833